Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» pralsetinib
pralsetinib
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
Xconomy
Blueprint Medicines
FDA
Gavreto
pralsetinib
cancer
RET
non-small cell lung cancer
Flag link:
Roche, Blueprint Medicines sign $1.7bn worth deal for pralsetinib
Roche, Blueprint Medicines sign $1.7bn worth deal for pralsetinib
Pharmaceutical Business Review
Roche
Blueprint Medicines
pralsetinib
RET-altered cancer
Flag link:
